Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obesity | 135 | 2022 | 2786 | 8.950 |
Why?
|
Hypertension | 100 | 2023 | 1245 | 8.880 |
Why?
|
Cardiovascular Diseases | 117 | 2023 | 1859 | 6.640 |
Why?
|
Blood Pressure | 108 | 2023 | 1713 | 5.830 |
Why?
|
Body Mass Index | 119 | 2023 | 2144 | 5.420 |
Why?
|
Hyperlipoproteinemia Type II | 13 | 2023 | 26 | 4.630 |
Why?
|
Child | 377 | 2023 | 19561 | 4.620 |
Why?
|
Adolescent | 364 | 2023 | 18948 | 4.260 |
Why?
|
Obesity, Morbid | 22 | 2019 | 204 | 3.360 |
Why?
|
Pediatric Obesity | 19 | 2021 | 541 | 3.290 |
Why?
|
Dyslipidemias | 22 | 2021 | 165 | 3.290 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 19 | 2022 | 66 | 3.170 |
Why?
|
Humans | 601 | 2024 | 122796 | 3.020 |
Why?
|
Pediatrics | 36 | 2023 | 1009 | 2.960 |
Why?
|
Metabolic Syndrome | 29 | 2015 | 395 | 2.900 |
Why?
|
Mass Screening | 21 | 2023 | 1095 | 2.740 |
Why?
|
Lipids | 33 | 2018 | 614 | 2.710 |
Why?
|
Cholesterol, LDL | 31 | 2023 | 326 | 2.620 |
Why?
|
Adiposity | 17 | 2022 | 523 | 2.490 |
Why?
|
Atherosclerosis | 23 | 2023 | 354 | 2.460 |
Why?
|
Hypertrophy, Left Ventricular | 26 | 2021 | 112 | 2.430 |
Why?
|
Diet | 27 | 2018 | 1168 | 2.260 |
Why?
|
Female | 368 | 2023 | 63629 | 2.190 |
Why?
|
Risk Factors | 134 | 2023 | 9381 | 2.180 |
Why?
|
Blood Pressure Determination | 18 | 2023 | 135 | 2.170 |
Why?
|
Primary Prevention | 8 | 2020 | 212 | 2.060 |
Why?
|
Adipose Tissue | 19 | 2022 | 616 | 1.970 |
Why?
|
Vascular Stiffness | 17 | 2023 | 429 | 1.920 |
Why?
|
Feeding Behavior | 17 | 2023 | 627 | 1.880 |
Why?
|
Male | 298 | 2023 | 59639 | 1.840 |
Why?
|
Child, Preschool | 124 | 2022 | 9755 | 1.800 |
Why?
|
Prevalence | 60 | 2021 | 2442 | 1.800 |
Why?
|
Hypercholesterolemia | 14 | 2017 | 96 | 1.690 |
Why?
|
Exercise | 27 | 2019 | 1743 | 1.680 |
Why?
|
Diabetes Mellitus, Type 2 | 39 | 2023 | 2221 | 1.660 |
Why?
|
Cholesterol | 19 | 2023 | 380 | 1.620 |
Why?
|
Infant Formula | 3 | 2019 | 84 | 1.590 |
Why?
|
Adult | 194 | 2023 | 32385 | 1.540 |
Why?
|
Weight Loss | 21 | 2019 | 663 | 1.540 |
Why?
|
Practice Guidelines as Topic | 25 | 2021 | 1519 | 1.490 |
Why?
|
Carotid Intima-Media Thickness | 11 | 2022 | 68 | 1.480 |
Why?
|
Diabetes Mellitus, Type 1 | 39 | 2023 | 3388 | 1.480 |
Why?
|
Pain, Postoperative | 9 | 2022 | 214 | 1.470 |
Why?
|
Body Composition | 16 | 2018 | 668 | 1.470 |
Why?
|
Insulin Resistance | 21 | 2022 | 1192 | 1.460 |
Why?
|
American Heart Association | 26 | 2022 | 313 | 1.440 |
Why?
|
Life Style | 19 | 2019 | 436 | 1.400 |
Why?
|
Longitudinal Studies | 52 | 2020 | 2599 | 1.390 |
Why?
|
Age Factors | 56 | 2020 | 3114 | 1.350 |
Why?
|
Carotid Arteries | 11 | 2015 | 189 | 1.350 |
Why?
|
Echocardiography | 47 | 2021 | 591 | 1.350 |
Why?
|
Body Weight | 24 | 2019 | 958 | 1.320 |
Why?
|
United States | 103 | 2022 | 13272 | 1.300 |
Why?
|
Gastric Bypass | 12 | 2017 | 93 | 1.290 |
Why?
|
Hypolipidemic Agents | 7 | 2012 | 88 | 1.280 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 10 | 2013 | 302 | 1.270 |
Why?
|
Puberty | 13 | 2018 | 149 | 1.270 |
Why?
|
Diet, Reducing | 10 | 2017 | 82 | 1.250 |
Why?
|
Antihypertensive Agents | 12 | 2018 | 465 | 1.240 |
Why?
|
Diclofenac | 6 | 2013 | 15 | 1.230 |
Why?
|
Body Constitution | 16 | 2007 | 47 | 1.220 |
Why?
|
Hyperlipidemias | 6 | 2012 | 134 | 1.190 |
Why?
|
Overweight | 13 | 2019 | 516 | 1.190 |
Why?
|
Bariatric Surgery | 11 | 2019 | 171 | 1.160 |
Why?
|
Energy Intake | 19 | 2020 | 453 | 1.160 |
Why?
|
Eating | 7 | 2023 | 379 | 1.150 |
Why?
|
Ventricular Dysfunction, Left | 11 | 2020 | 401 | 1.140 |
Why?
|
Heart Defects, Congenital | 13 | 2019 | 721 | 1.130 |
Why?
|
Cholesterol, HDL | 19 | 2023 | 202 | 1.130 |
Why?
|
Risk Reduction Behavior | 13 | 2014 | 205 | 1.130 |
Why?
|
White Coat Hypertension | 2 | 2022 | 3 | 1.120 |
Why?
|
Young Adult | 76 | 2023 | 11094 | 1.090 |
Why?
|
Feeding and Eating Disorders | 9 | 2005 | 127 | 1.060 |
Why?
|
Regression Analysis | 34 | 2014 | 1018 | 1.050 |
Why?
|
Risk Assessment | 24 | 2022 | 3213 | 1.030 |
Why?
|
Ventricular Function, Left | 20 | 2006 | 493 | 1.010 |
Why?
|
Diabetes Complications | 9 | 2019 | 226 | 1.000 |
Why?
|
Health Promotion | 12 | 2019 | 707 | 1.000 |
Why?
|
Double-Blind Method | 22 | 2022 | 1711 | 0.990 |
Why?
|
Health Status | 7 | 2016 | 758 | 0.990 |
Why?
|
Kidney Failure, Chronic | 10 | 2008 | 519 | 0.990 |
Why?
|
Sleep Apnea Syndromes | 6 | 2008 | 88 | 0.970 |
Why?
|
Motor Activity | 14 | 2018 | 679 | 0.970 |
Why?
|
Cardiovascular System | 6 | 2021 | 132 | 0.970 |
Why?
|
Heart Rate | 18 | 2019 | 756 | 0.950 |
Why?
|
Prehypertension | 3 | 2012 | 27 | 0.940 |
Why?
|
Sleep Apnea, Obstructive | 10 | 2020 | 237 | 0.940 |
Why?
|
Fasting | 8 | 2020 | 266 | 0.930 |
Why?
|
Systole | 17 | 2019 | 178 | 0.920 |
Why?
|
Physical Fitness | 6 | 2013 | 184 | 0.910 |
Why?
|
Infant | 66 | 2019 | 8523 | 0.900 |
Why?
|
Dietary Carbohydrates | 9 | 2015 | 154 | 0.900 |
Why?
|
Cardiovascular Agents | 2 | 2014 | 140 | 0.900 |
Why?
|
Proprotein Convertase 9 | 2 | 2022 | 61 | 0.890 |
Why?
|
Pulse Wave Analysis | 11 | 2023 | 216 | 0.880 |
Why?
|
Child Behavior | 8 | 2020 | 238 | 0.880 |
Why?
|
Adolescent Behavior | 10 | 2020 | 495 | 0.870 |
Why?
|
Arteriosclerosis | 11 | 2013 | 90 | 0.860 |
Why?
|
Bulimia Nervosa | 3 | 2007 | 18 | 0.860 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 7 | 2018 | 77 | 0.860 |
Why?
|
Naproxen | 4 | 2016 | 12 | 0.850 |
Why?
|
Ohio | 24 | 2016 | 144 | 0.850 |
Why?
|
Anticholesteremic Agents | 6 | 2020 | 136 | 0.840 |
Why?
|
Follow-Up Studies | 38 | 2020 | 4768 | 0.840 |
Why?
|
Diastole | 18 | 2020 | 147 | 0.830 |
Why?
|
Prospective Studies | 40 | 2023 | 6704 | 0.830 |
Why?
|
Exercise Test | 16 | 2018 | 588 | 0.820 |
Why?
|
Waist Circumference | 16 | 2015 | 132 | 0.820 |
Why?
|
Child Health | 3 | 2020 | 142 | 0.810 |
Why?
|
Triglycerides | 24 | 2020 | 527 | 0.800 |
Why?
|
Anthropometry | 16 | 2018 | 200 | 0.790 |
Why?
|
Cohort Studies | 45 | 2021 | 5294 | 0.790 |
Why?
|
Laparoscopy | 4 | 2017 | 426 | 0.780 |
Why?
|
Maternal Health | 1 | 2021 | 45 | 0.770 |
Why?
|
Sex Factors | 27 | 2017 | 1860 | 0.760 |
Why?
|
Coronary Aneurysm | 3 | 2018 | 11 | 0.750 |
Why?
|
Heart | 12 | 2023 | 649 | 0.750 |
Why?
|
Depression | 8 | 2012 | 1190 | 0.750 |
Why?
|
Dysmenorrhea | 3 | 2009 | 6 | 0.740 |
Why?
|
Blood Glucose | 20 | 2020 | 1957 | 0.730 |
Why?
|
Absorptiometry, Photon | 14 | 2018 | 230 | 0.720 |
Why?
|
Circadian Rhythm | 6 | 2014 | 414 | 0.710 |
Why?
|
Treatment Outcome | 28 | 2020 | 9692 | 0.700 |
Why?
|
Heart Ventricles | 22 | 2014 | 741 | 0.700 |
Why?
|
Heterozygote | 1 | 2020 | 270 | 0.690 |
Why?
|
Oil and Gas Fields | 1 | 2019 | 35 | 0.690 |
Why?
|
Fruit | 8 | 2020 | 134 | 0.690 |
Why?
|
Body Height | 14 | 2018 | 194 | 0.680 |
Why?
|
Deafness | 2 | 2018 | 80 | 0.680 |
Why?
|
Food | 4 | 2016 | 164 | 0.670 |
Why?
|
Infant, Newborn | 36 | 2019 | 5430 | 0.670 |
Why?
|
Maternal Exposure | 3 | 2019 | 148 | 0.660 |
Why?
|
Adenoidectomy | 4 | 2020 | 60 | 0.660 |
Why?
|
Nervous System Malformations | 1 | 2018 | 33 | 0.650 |
Why?
|
Child Development | 5 | 2016 | 449 | 0.650 |
Why?
|
Phenols | 2 | 2009 | 87 | 0.650 |
Why?
|
Reference Values | 27 | 2017 | 789 | 0.650 |
Why?
|
Predictive Value of Tests | 17 | 2017 | 1947 | 0.650 |
Why?
|
Walk Test | 1 | 2018 | 54 | 0.650 |
Why?
|
Biomarkers | 10 | 2020 | 3662 | 0.650 |
Why?
|
Aortic Coarctation | 7 | 2019 | 57 | 0.650 |
Why?
|
Advisory Committees | 2 | 2016 | 229 | 0.630 |
Why?
|
Vegetables | 8 | 2020 | 140 | 0.630 |
Why?
|
Adiponectin | 8 | 2012 | 231 | 0.630 |
Why?
|
Internationality | 3 | 2015 | 158 | 0.630 |
Why?
|
Tooth Extraction | 5 | 2016 | 21 | 0.630 |
Why?
|
Preventive Health Services | 3 | 2017 | 144 | 0.630 |
Why?
|
Morbidity | 4 | 2017 | 309 | 0.630 |
Why?
|
Incidence | 21 | 2020 | 2527 | 0.630 |
Why?
|
Diabetic Angiopathies | 8 | 2019 | 270 | 0.620 |
Why?
|
Depressive Disorder, Major | 2 | 2019 | 309 | 0.620 |
Why?
|
Diet Records | 13 | 2020 | 81 | 0.620 |
Why?
|
Tonsillectomy | 4 | 2020 | 78 | 0.620 |
Why?
|
Fruit and Vegetable Juices | 1 | 2017 | 15 | 0.610 |
Why?
|
Decision Making | 2 | 2014 | 840 | 0.610 |
Why?
|
Sleep | 7 | 2019 | 722 | 0.600 |
Why?
|
Anti-Obesity Agents | 5 | 2018 | 49 | 0.590 |
Why?
|
Plasma Gases | 3 | 2023 | 5 | 0.580 |
Why?
|
Diet, Carbohydrate-Restricted | 2 | 2017 | 31 | 0.570 |
Why?
|
Caloric Restriction | 2 | 2009 | 91 | 0.570 |
Why?
|
Accelerometry | 2 | 2014 | 83 | 0.570 |
Why?
|
Air Pollution | 1 | 2019 | 221 | 0.570 |
Why?
|
Adolescent Development | 3 | 2012 | 85 | 0.570 |
Why?
|
Cardiology | 7 | 2019 | 338 | 0.560 |
Why?
|
Graphite | 1 | 2016 | 12 | 0.560 |
Why?
|
Intra-Abdominal Fat | 2 | 2015 | 98 | 0.560 |
Why?
|
Time Factors | 32 | 2020 | 6682 | 0.560 |
Why?
|
Gastroplasty | 3 | 2005 | 26 | 0.560 |
Why?
|
Ketorolac | 2 | 2013 | 19 | 0.560 |
Why?
|
Brachial Artery | 5 | 2013 | 183 | 0.560 |
Why?
|
Nanotechnology | 3 | 2016 | 122 | 0.560 |
Why?
|
Bulimia | 3 | 2006 | 26 | 0.550 |
Why?
|
Beverages | 3 | 2017 | 70 | 0.550 |
Why?
|
Self Disclosure | 2 | 2006 | 62 | 0.550 |
Why?
|
Biomedical Research | 6 | 2019 | 630 | 0.550 |
Why?
|
Cross-Sectional Studies | 36 | 2021 | 4734 | 0.550 |
Why?
|
Population Surveillance | 4 | 2019 | 439 | 0.540 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2020 | 658 | 0.540 |
Why?
|
Monitoring, Physiologic | 4 | 2013 | 288 | 0.540 |
Why?
|
Body Image | 3 | 2004 | 72 | 0.540 |
Why?
|
Central Nervous System Stimulants | 2 | 2009 | 143 | 0.530 |
Why?
|
Carbonated Beverages | 2 | 2006 | 19 | 0.530 |
Why?
|
Nutritional Requirements | 3 | 2012 | 83 | 0.520 |
Why?
|
Wind | 1 | 2014 | 14 | 0.520 |
Why?
|
Hallux Valgus | 4 | 2016 | 29 | 0.510 |
Why?
|
Physician's Role | 3 | 2016 | 207 | 0.510 |
Why?
|
Hearing Loss | 1 | 2018 | 190 | 0.510 |
Why?
|
Nanostructures | 1 | 2016 | 102 | 0.510 |
Why?
|
Caffeine | 2 | 2006 | 64 | 0.510 |
Why?
|
Case-Control Studies | 15 | 2019 | 3296 | 0.510 |
Why?
|
Rain | 1 | 2014 | 34 | 0.500 |
Why?
|
Health Status Indicators | 3 | 2020 | 163 | 0.500 |
Why?
|
Faculty, Medical | 4 | 2012 | 258 | 0.490 |
Why?
|
Walking | 1 | 2018 | 435 | 0.490 |
Why?
|
Micronutrients | 2 | 2012 | 83 | 0.490 |
Why?
|
Diabetes Mellitus | 6 | 2016 | 985 | 0.490 |
Why?
|
Schools | 4 | 2017 | 428 | 0.490 |
Why?
|
Emigrants and Immigrants | 1 | 2016 | 122 | 0.490 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2017 | 232 | 0.480 |
Why?
|
Kidney Transplantation | 4 | 2019 | 584 | 0.480 |
Why?
|
Regional Blood Flow | 2 | 2015 | 427 | 0.480 |
Why?
|
Societies, Medical | 9 | 2020 | 741 | 0.480 |
Why?
|
Orthopedic Procedures | 3 | 2016 | 221 | 0.470 |
Why?
|
Comorbidity | 15 | 2017 | 1600 | 0.470 |
Why?
|
Ibuprofen | 2 | 2016 | 76 | 0.470 |
Why?
|
Middle Aged | 56 | 2020 | 28563 | 0.470 |
Why?
|
Public Health | 6 | 2014 | 480 | 0.470 |
Why?
|
Disease Management | 4 | 2012 | 591 | 0.470 |
Why?
|
Severity of Illness Index | 19 | 2017 | 2784 | 0.460 |
Why?
|
Multivariate Analysis | 11 | 2021 | 1531 | 0.460 |
Why?
|
Age of Onset | 15 | 2013 | 479 | 0.460 |
Why?
|
Patient Compliance | 6 | 2014 | 561 | 0.450 |
Why?
|
Attitude to Health | 5 | 2006 | 417 | 0.450 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 7 | 2021 | 410 | 0.450 |
Why?
|
Cyclooxygenase Inhibitors | 3 | 2009 | 72 | 0.450 |
Why?
|
Growth Charts | 1 | 2012 | 16 | 0.450 |
Why?
|
Coronary Disease | 9 | 2011 | 372 | 0.450 |
Why?
|
Ventricular Remodeling | 3 | 2020 | 230 | 0.450 |
Why?
|
Parents | 8 | 2019 | 1256 | 0.440 |
Why?
|
Dietary Fats | 10 | 2012 | 325 | 0.440 |
Why?
|
Nutrition Surveys | 6 | 2015 | 240 | 0.440 |
Why?
|
Family | 4 | 2007 | 595 | 0.440 |
Why?
|
Disinfection | 2 | 2024 | 102 | 0.430 |
Why?
|
Smoking | 10 | 2020 | 1556 | 0.430 |
Why?
|
Social Justice | 3 | 2023 | 63 | 0.420 |
Why?
|
Health Services Accessibility | 2 | 2016 | 813 | 0.420 |
Why?
|
Disease Progression | 10 | 2019 | 2546 | 0.420 |
Why?
|
Temperature | 1 | 2014 | 631 | 0.410 |
Why?
|
Cyclooxygenase 2 Inhibitors | 3 | 2022 | 20 | 0.410 |
Why?
|
Metabolic Diseases | 3 | 2016 | 104 | 0.410 |
Why?
|
Vascular Resistance | 6 | 2011 | 374 | 0.410 |
Why?
|
Hemodynamics | 14 | 2012 | 1036 | 0.410 |
Why?
|
Breast Feeding | 3 | 2016 | 398 | 0.410 |
Why?
|
Ductus Arteriosus, Patent | 4 | 2009 | 50 | 0.400 |
Why?
|
Forecasting | 6 | 2020 | 372 | 0.400 |
Why?
|
Health Behavior | 10 | 2020 | 731 | 0.400 |
Why?
|
Surveys and Questionnaires | 19 | 2017 | 4882 | 0.400 |
Why?
|
Career Mobility | 1 | 2012 | 67 | 0.400 |
Why?
|
Tunica Media | 5 | 2011 | 38 | 0.400 |
Why?
|
Logistic Models | 10 | 2019 | 1995 | 0.400 |
Why?
|
Sexual Maturation | 5 | 2018 | 51 | 0.390 |
Why?
|
Demography | 5 | 2016 | 290 | 0.390 |
Why?
|
Food Preferences | 3 | 2011 | 133 | 0.390 |
Why?
|
Cross Infection | 3 | 2022 | 218 | 0.390 |
Why?
|
Dietary Sucrose | 3 | 2015 | 55 | 0.390 |
Why?
|
Polysomnography | 10 | 2012 | 177 | 0.380 |
Why?
|
Cyclobutanes | 2 | 2007 | 7 | 0.380 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2022 | 194 | 0.380 |
Why?
|
Appetite Depressants | 2 | 2007 | 21 | 0.380 |
Why?
|
Nervous System Diseases | 2 | 2023 | 265 | 0.370 |
Why?
|
Academic Medical Centers | 2 | 2016 | 427 | 0.370 |
Why?
|
Family Health | 5 | 2012 | 201 | 0.370 |
Why?
|
Mothers | 3 | 2012 | 728 | 0.360 |
Why?
|
Acute Pain | 3 | 2016 | 32 | 0.360 |
Why?
|
Environmental Microbiology | 3 | 2015 | 44 | 0.360 |
Why?
|
Self Concept | 7 | 2007 | 221 | 0.360 |
Why?
|
Hyperinsulinism | 5 | 2011 | 109 | 0.350 |
Why?
|
Sulfonamides | 4 | 2013 | 455 | 0.350 |
Why?
|
Lipoproteins | 10 | 2023 | 164 | 0.350 |
Why?
|
Methylphenidate | 1 | 2009 | 37 | 0.350 |
Why?
|
Poloxamer | 1 | 2009 | 13 | 0.350 |
Why?
|
Insulin | 12 | 2020 | 2180 | 0.340 |
Why?
|
Neurotransmitter Agents | 1 | 2009 | 76 | 0.340 |
Why?
|
Diabetes, Gestational | 4 | 2018 | 285 | 0.340 |
Why?
|
Heart Murmurs | 1 | 2009 | 12 | 0.340 |
Why?
|
Colorado | 11 | 2019 | 4325 | 0.340 |
Why?
|
Sweetening Agents | 1 | 2009 | 53 | 0.340 |
Why?
|
Evidence-Based Medicine | 8 | 2012 | 731 | 0.340 |
Why?
|
Oxycodone | 1 | 2009 | 45 | 0.340 |
Why?
|
Bone Density | 3 | 2010 | 451 | 0.340 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2016 | 1981 | 0.330 |
Why?
|
Health Surveys | 9 | 2020 | 468 | 0.330 |
Why?
|
Oligomenorrhea | 3 | 2015 | 6 | 0.330 |
Why?
|
Pyrazoles | 4 | 2013 | 366 | 0.330 |
Why?
|
Pain Measurement | 5 | 2013 | 481 | 0.330 |
Why?
|
Racism | 2 | 2020 | 108 | 0.330 |
Why?
|
Pregnancy | 15 | 2021 | 5854 | 0.330 |
Why?
|
Bariatrics | 2 | 2005 | 5 | 0.330 |
Why?
|
Sodium, Dietary | 7 | 2015 | 44 | 0.330 |
Why?
|
Tunica Intima | 5 | 2011 | 79 | 0.320 |
Why?
|
Birth Weight | 4 | 2018 | 473 | 0.320 |
Why?
|
Hand Strength | 1 | 2009 | 106 | 0.320 |
Why?
|
Genetic Testing | 3 | 2021 | 400 | 0.320 |
Why?
|
Thinness | 4 | 2015 | 94 | 0.320 |
Why?
|
Eosinophilia-Myalgia Syndrome | 3 | 1996 | 3 | 0.320 |
Why?
|
Milk | 1 | 2009 | 127 | 0.320 |
Why?
|
Growth Hormone | 1 | 2008 | 109 | 0.310 |
Why?
|
Diet, Fat-Restricted | 4 | 2007 | 76 | 0.310 |
Why?
|
Growth Disorders | 1 | 2008 | 82 | 0.310 |
Why?
|
Infant, Small for Gestational Age | 1 | 2008 | 74 | 0.310 |
Why?
|
Transition to Adult Care | 3 | 2019 | 60 | 0.310 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2009 | 122 | 0.300 |
Why?
|
Linear Models | 10 | 2013 | 854 | 0.300 |
Why?
|
Gastrointestinal Tract | 1 | 2009 | 176 | 0.300 |
Why?
|
Counseling | 3 | 2017 | 364 | 0.300 |
Why?
|
Anorexia Nervosa | 3 | 2006 | 76 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2019 | 602 | 0.290 |
Why?
|
Hypertension, Pulmonary | 3 | 2017 | 1900 | 0.290 |
Why?
|
Cardiac Output | 8 | 2005 | 154 | 0.290 |
Why?
|
Myocardial Contraction | 14 | 2005 | 339 | 0.290 |
Why?
|
Dairy Products | 3 | 2012 | 31 | 0.290 |
Why?
|
Aged | 29 | 2016 | 20495 | 0.290 |
Why?
|
Tryptophan | 3 | 1996 | 140 | 0.290 |
Why?
|
Nitrites | 2 | 2024 | 81 | 0.290 |
Why?
|
Apolipoproteins B | 4 | 2014 | 44 | 0.290 |
Why?
|
Pediatricians | 2 | 2019 | 121 | 0.290 |
Why?
|
Peripheral Arterial Disease | 1 | 2012 | 398 | 0.290 |
Why?
|
Menarche | 5 | 2018 | 51 | 0.280 |
Why?
|
Parent-Child Relations | 2 | 2004 | 246 | 0.280 |
Why?
|
Child Nutritional Physiological Phenomena | 6 | 2016 | 99 | 0.280 |
Why?
|
Health Services | 2 | 2005 | 110 | 0.280 |
Why?
|
Age Distribution | 7 | 2015 | 376 | 0.280 |
Why?
|
Weaning | 1 | 2006 | 59 | 0.280 |
Why?
|
Sleep Wake Disorders | 3 | 2018 | 289 | 0.280 |
Why?
|
Uric Acid | 1 | 2009 | 354 | 0.280 |
Why?
|
Sensitivity and Specificity | 11 | 2021 | 1855 | 0.270 |
Why?
|
Nutrition Assessment | 3 | 2015 | 78 | 0.270 |
Why?
|
Organ Transplantation | 2 | 2019 | 165 | 0.270 |
Why?
|
Acetaminophen | 1 | 2009 | 261 | 0.270 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 6 | 2016 | 25 | 0.270 |
Why?
|
Nutrition Policy | 6 | 2017 | 60 | 0.270 |
Why?
|
Guidelines as Topic | 5 | 2019 | 273 | 0.270 |
Why?
|
Child Welfare | 5 | 2012 | 201 | 0.270 |
Why?
|
Organ Size | 5 | 2010 | 474 | 0.270 |
Why?
|
Quality of Health Care | 2 | 2016 | 631 | 0.270 |
Why?
|
Maternal Behavior | 1 | 2006 | 76 | 0.270 |
Why?
|
Escherichia coli | 2 | 2024 | 767 | 0.270 |
Why?
|
Dyssomnias | 1 | 2005 | 3 | 0.270 |
Why?
|
Bronchopulmonary Dysplasia | 2 | 2009 | 337 | 0.270 |
Why?
|
Research | 4 | 2017 | 432 | 0.260 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 374 | 0.260 |
Why?
|
Research Design | 5 | 2018 | 1002 | 0.260 |
Why?
|
Autonomic Nervous System Diseases | 2 | 2022 | 27 | 0.260 |
Why?
|
Myocardium | 3 | 2008 | 982 | 0.260 |
Why?
|
Aging | 8 | 2009 | 1694 | 0.260 |
Why?
|
Phosphorus | 1 | 2005 | 85 | 0.260 |
Why?
|
Epigenesis, Genetic | 1 | 2009 | 551 | 0.260 |
Why?
|
Cluster Analysis | 3 | 2015 | 493 | 0.260 |
Why?
|
Beriberi | 1 | 2004 | 1 | 0.260 |
Why?
|
Hydrogen Peroxide | 2 | 2023 | 299 | 0.250 |
Why?
|
Cost-Benefit Analysis | 3 | 2019 | 573 | 0.250 |
Why?
|
Self Report | 3 | 2020 | 730 | 0.250 |
Why?
|
Somatoform Disorders | 1 | 2004 | 41 | 0.250 |
Why?
|
Finland | 7 | 2020 | 73 | 0.250 |
Why?
|
Stress, Psychological | 4 | 2006 | 1021 | 0.250 |
Why?
|
Psychology, Child | 1 | 2004 | 40 | 0.250 |
Why?
|
Mental Recall | 2 | 2013 | 185 | 0.250 |
Why?
|
Digestive System Surgical Procedures | 1 | 2005 | 93 | 0.250 |
Why?
|
Psychology, Adolescent | 1 | 2004 | 64 | 0.250 |
Why?
|
Pain | 2 | 2009 | 746 | 0.250 |
Why?
|
Calcium, Dietary | 5 | 2007 | 55 | 0.250 |
Why?
|
Brain | 4 | 2018 | 2540 | 0.240 |
Why?
|
Play and Playthings | 1 | 2004 | 33 | 0.240 |
Why?
|
Models, Statistical | 6 | 2013 | 651 | 0.240 |
Why?
|
Weight Gain | 5 | 2018 | 511 | 0.240 |
Why?
|
Medical History Taking | 2 | 2022 | 121 | 0.240 |
Why?
|
Postoperative Complications | 10 | 2006 | 2301 | 0.240 |
Why?
|
Patient Dropouts | 1 | 2004 | 69 | 0.240 |
Why?
|
Retrospective Studies | 33 | 2019 | 13433 | 0.240 |
Why?
|
Quality of Life | 4 | 2009 | 2457 | 0.240 |
Why?
|
Life Change Events | 1 | 2004 | 138 | 0.230 |
Why?
|
Hospitals | 4 | 2022 | 633 | 0.230 |
Why?
|
Non-alcoholic Fatty Liver Disease | 2 | 2017 | 284 | 0.230 |
Why?
|
Kidney Diseases | 4 | 2007 | 446 | 0.230 |
Why?
|
Primary Health Care | 5 | 2015 | 1625 | 0.230 |
Why?
|
Abdominal Cavity | 1 | 2003 | 5 | 0.230 |
Why?
|
Program Evaluation | 2 | 2007 | 880 | 0.230 |
Why?
|
Congresses as Topic | 2 | 2019 | 208 | 0.230 |
Why?
|
Meat | 4 | 2012 | 93 | 0.230 |
Why?
|
Burns | 5 | 1994 | 256 | 0.230 |
Why?
|
Hypertriglyceridemia | 3 | 2011 | 39 | 0.230 |
Why?
|
Indomethacin | 2 | 2013 | 76 | 0.230 |
Why?
|
Skinfold Thickness | 6 | 2009 | 49 | 0.230 |
Why?
|
Myocardial Ischemia | 4 | 2008 | 267 | 0.220 |
Why?
|
Heart Diseases | 4 | 2008 | 358 | 0.220 |
Why?
|
Education, Medical, Graduate | 3 | 2014 | 432 | 0.220 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2019 | 101 | 0.220 |
Why?
|
Phantoms, Imaging | 1 | 2003 | 154 | 0.210 |
Why?
|
Analgesics, Opioid | 4 | 2022 | 785 | 0.210 |
Why?
|
Tramadol | 1 | 2022 | 19 | 0.210 |
Why?
|
Renal Dialysis | 5 | 2005 | 395 | 0.210 |
Why?
|
Celecoxib | 5 | 2022 | 39 | 0.210 |
Why?
|
Bacteriophages | 1 | 2023 | 75 | 0.210 |
Why?
|
Saliva | 1 | 2023 | 215 | 0.210 |
Why?
|
Masked Hypertension | 1 | 2021 | 1 | 0.210 |
Why?
|
Food Safety | 2 | 2019 | 17 | 0.210 |
Why?
|
Stroke | 7 | 2019 | 1090 | 0.210 |
Why?
|
Reference Standards | 5 | 2023 | 177 | 0.210 |
Why?
|
Retinal Vessels | 2 | 1993 | 53 | 0.210 |
Why?
|
Carotid Artery Diseases | 2 | 2013 | 61 | 0.210 |
Why?
|
Health Policy | 3 | 2013 | 356 | 0.210 |
Why?
|
Guideline Adherence | 4 | 2017 | 560 | 0.210 |
Why?
|
Reproducibility of Results | 11 | 2016 | 2977 | 0.210 |
Why?
|
Nicardipine | 1 | 2001 | 7 | 0.210 |
Why?
|
Arteries | 4 | 2010 | 256 | 0.210 |
Why?
|
Nifedipine | 1 | 2001 | 30 | 0.200 |
Why?
|
Research Personnel | 1 | 2023 | 158 | 0.200 |
Why?
|
Terminology as Topic | 3 | 2017 | 217 | 0.200 |
Why?
|
Energy Metabolism | 4 | 2006 | 783 | 0.200 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2012 | 1213 | 0.200 |
Why?
|
Hepatolenticular Degeneration | 1 | 2001 | 18 | 0.200 |
Why?
|
Fatty Liver | 3 | 2009 | 254 | 0.200 |
Why?
|
Gastroenterology | 2 | 2017 | 162 | 0.200 |
Why?
|
Benchmarking | 1 | 2022 | 184 | 0.200 |
Why?
|
Hypoglycemic Agents | 1 | 2009 | 1055 | 0.200 |
Why?
|
High Fructose Corn Syrup | 2 | 2018 | 10 | 0.200 |
Why?
|
Patient Selection | 4 | 2006 | 717 | 0.200 |
Why?
|
Whole Grains | 1 | 2020 | 3 | 0.200 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2001 | 39 | 0.190 |
Why?
|
Sex Characteristics | 7 | 2006 | 690 | 0.190 |
Why?
|
Research Support as Topic | 2 | 2019 | 122 | 0.190 |
Why?
|
Baroreflex | 2 | 2012 | 53 | 0.190 |
Why?
|
Risk | 8 | 2012 | 890 | 0.190 |
Why?
|
Genetic Predisposition to Disease | 3 | 2012 | 2359 | 0.190 |
Why?
|
Physicians | 2 | 2008 | 824 | 0.190 |
Why?
|
Silicones | 2 | 1997 | 21 | 0.190 |
Why?
|
Diabetic Neuropathies | 2 | 2019 | 100 | 0.190 |
Why?
|
Drug Administration Schedule | 6 | 2016 | 757 | 0.190 |
Why?
|
Epidemiologic Methods | 3 | 1996 | 75 | 0.190 |
Why?
|
Breast Implants | 2 | 1997 | 14 | 0.190 |
Why?
|
Microbiological Techniques | 1 | 2020 | 32 | 0.180 |
Why?
|
Carotid Artery, Common | 1 | 2020 | 30 | 0.180 |
Why?
|
Prognosis | 9 | 2019 | 3563 | 0.180 |
Why?
|
Sphygmomanometers | 2 | 2012 | 7 | 0.180 |
Why?
|
Behavior Therapy | 4 | 2006 | 249 | 0.180 |
Why?
|
Equipment Contamination | 1 | 2020 | 56 | 0.180 |
Why?
|
Placebos | 3 | 2009 | 204 | 0.180 |
Why?
|
Copper | 2 | 2016 | 101 | 0.180 |
Why?
|
Ultrasonography | 10 | 2011 | 740 | 0.180 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 83 | 0.180 |
Why?
|
Calcium | 2 | 2005 | 1244 | 0.180 |
Why?
|
Eggs | 2 | 2018 | 29 | 0.180 |
Why?
|
Australia | 5 | 2020 | 223 | 0.180 |
Why?
|
Graft Rejection | 3 | 1997 | 556 | 0.180 |
Why?
|
Emigration and Immigration | 1 | 2000 | 52 | 0.180 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 8 | 0.180 |
Why?
|
Imaging, Three-Dimensional | 1 | 2003 | 511 | 0.180 |
Why?
|
Food Contamination | 1 | 2019 | 45 | 0.170 |
Why?
|
Food Assistance | 1 | 2019 | 16 | 0.170 |
Why?
|
Pilot Projects | 3 | 2020 | 1477 | 0.170 |
Why?
|
Volunteers | 1 | 2019 | 33 | 0.170 |
Why?
|
Stroke Volume | 5 | 2020 | 553 | 0.170 |
Why?
|
Image Enhancement | 2 | 1997 | 185 | 0.170 |
Why?
|
C-Reactive Protein | 3 | 2012 | 363 | 0.170 |
Why?
|
Puberty, Precocious | 1 | 2018 | 14 | 0.170 |
Why?
|
Competency-Based Education | 2 | 2016 | 68 | 0.170 |
Why?
|
Vitamins | 2 | 2012 | 163 | 0.170 |
Why?
|
Social Class | 4 | 2018 | 231 | 0.170 |
Why?
|
Clinical Trials as Topic | 6 | 2007 | 985 | 0.170 |
Why?
|
Receptors, Opioid, mu | 2 | 2016 | 52 | 0.170 |
Why?
|
Smokers | 1 | 2020 | 169 | 0.170 |
Why?
|
Surface Properties | 3 | 2016 | 402 | 0.170 |
Why?
|
Global Health | 2 | 2020 | 352 | 0.170 |
Why?
|
Donor Selection | 1 | 2019 | 73 | 0.170 |
Why?
|
Pharmacology | 1 | 2018 | 9 | 0.170 |
Why?
|
Salaries and Fringe Benefits | 2 | 2012 | 55 | 0.170 |
Why?
|
Biosensing Techniques | 2 | 2010 | 111 | 0.170 |
Why?
|
Socioeconomic Factors | 6 | 2015 | 1158 | 0.170 |
Why?
|
Body Fat Distribution | 2 | 2010 | 46 | 0.170 |
Why?
|
Photoelectron Spectroscopy | 2 | 2016 | 6 | 0.170 |
Why?
|
Clinical Competence | 5 | 2016 | 973 | 0.170 |
Why?
|
Hemofiltration | 1 | 1998 | 34 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 739 | 0.160 |
Why?
|
Potassium, Dietary | 2 | 2015 | 11 | 0.160 |
Why?
|
School Health Services | 3 | 2013 | 207 | 0.160 |
Why?
|
Health Education | 5 | 2013 | 332 | 0.160 |
Why?
|
Smoking Cessation | 2 | 2020 | 363 | 0.160 |
Why?
|
Social Determinants of Health | 1 | 2020 | 141 | 0.160 |
Why?
|
Sex Distribution | 4 | 2010 | 370 | 0.160 |
Why?
|
Postoperative Care | 2 | 2005 | 245 | 0.160 |
Why?
|
Bupropion | 1 | 2018 | 40 | 0.160 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 186 | 0.160 |
Why?
|
Health Status Disparities | 1 | 2020 | 217 | 0.160 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 392 | 0.160 |
Why?
|
Social Media | 2 | 2019 | 163 | 0.160 |
Why?
|
Cardiac Surgical Procedures | 2 | 2018 | 477 | 0.160 |
Why?
|
Glutathione | 1 | 1999 | 327 | 0.160 |
Why?
|
Zinc | 1 | 2001 | 266 | 0.160 |
Why?
|
Coronary Vessels | 2 | 2018 | 237 | 0.160 |
Why?
|
Biochemistry | 1 | 2018 | 40 | 0.160 |
Why?
|
Microscopy, Atomic Force | 2 | 2016 | 119 | 0.160 |
Why?
|
Antidepressive Agents | 1 | 2019 | 194 | 0.160 |
Why?
|
Seasons | 2 | 2014 | 468 | 0.160 |
Why?
|
Survival Rate | 3 | 2020 | 1810 | 0.160 |
Why?
|
Spores, Bacterial | 2 | 2014 | 20 | 0.160 |
Why?
|
Blood Flow Velocity | 7 | 2011 | 333 | 0.160 |
Why?
|
Bacteria | 3 | 2024 | 772 | 0.160 |
Why?
|
Pulmonary Valve Stenosis | 1 | 1997 | 18 | 0.160 |
Why?
|
Education, Medical, Continuing | 2 | 2016 | 140 | 0.160 |
Why?
|
Portion Size | 1 | 2017 | 7 | 0.150 |
Why?
|
Communicable Disease Control | 1 | 2018 | 74 | 0.150 |
Why?
|
Costs and Cost Analysis | 2 | 2018 | 211 | 0.150 |
Why?
|
Naltrexone | 1 | 2018 | 76 | 0.150 |
Why?
|
Role | 1 | 1997 | 33 | 0.150 |
Why?
|
Pregnancy in Diabetics | 1 | 2018 | 89 | 0.150 |
Why?
|
Heart Transplantation | 5 | 2007 | 674 | 0.150 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2019 | 531 | 0.150 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2012 | 49 | 0.150 |
Why?
|
Dobutamine | 1 | 1997 | 36 | 0.150 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2018 | 511 | 0.150 |
Why?
|
Endothelium, Vascular | 5 | 2018 | 923 | 0.150 |
Why?
|
World Health Organization | 3 | 2014 | 115 | 0.150 |
Why?
|
History, 20th Century | 3 | 2019 | 288 | 0.150 |
Why?
|
Toothache | 1 | 2016 | 5 | 0.150 |
Why?
|
Disease Susceptibility | 2 | 2009 | 343 | 0.150 |
Why?
|
Insurance, Health | 2 | 2009 | 259 | 0.150 |
Why?
|
Probability | 4 | 2009 | 316 | 0.150 |
Why?
|
Mindfulness | 1 | 2018 | 103 | 0.140 |
Why?
|
Referral and Consultation | 4 | 2020 | 669 | 0.140 |
Why?
|
Psoriasis | 1 | 2017 | 86 | 0.140 |
Why?
|
Anxiety Disorders | 1 | 2019 | 326 | 0.140 |
Why?
|
Autonomic Nervous System | 2 | 2013 | 67 | 0.140 |
Why?
|
Algorithms | 4 | 2009 | 1593 | 0.140 |
Why?
|
Argon | 1 | 2016 | 20 | 0.140 |
Why?
|
Mammaplasty | 1 | 1997 | 71 | 0.140 |
Why?
|
Molar, Third | 3 | 2012 | 10 | 0.140 |
Why?
|
Spiro Compounds | 1 | 2016 | 11 | 0.140 |
Why?
|
Vascular Diseases | 3 | 2010 | 251 | 0.140 |
Why?
|
Elasticity | 3 | 2011 | 192 | 0.140 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 1306 | 0.140 |
Why?
|
Acute Disease | 2 | 2009 | 984 | 0.140 |
Why?
|
Cross-Over Studies | 4 | 2012 | 469 | 0.140 |
Why?
|
Injections, Intravenous | 2 | 2013 | 217 | 0.140 |
Why?
|
Body Size | 2 | 2014 | 95 | 0.140 |
Why?
|
Spectrum Analysis, Raman | 1 | 2016 | 48 | 0.140 |
Why?
|
Odds Ratio | 7 | 2011 | 1043 | 0.140 |
Why?
|
Memory, Short-Term | 1 | 2018 | 250 | 0.140 |
Why?
|
Blood Pressure Monitors | 1 | 2015 | 2 | 0.140 |
Why?
|
Tetrahydroisoquinolines | 2 | 2007 | 8 | 0.140 |
Why?
|
Heart Failure | 9 | 2008 | 2114 | 0.140 |
Why?
|
Glomerular Filtration Rate | 3 | 2006 | 697 | 0.130 |
Why?
|
Policy Making | 1 | 2016 | 91 | 0.130 |
Why?
|
Diet Surveys | 3 | 2020 | 86 | 0.130 |
Why?
|
Internship and Residency | 4 | 2015 | 1065 | 0.130 |
Why?
|
Colectomy | 1 | 2016 | 89 | 0.130 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 1996 | 113 | 0.130 |
Why?
|
Hygiene | 1 | 2015 | 35 | 0.130 |
Why?
|
Drug Combinations | 4 | 2022 | 292 | 0.130 |
Why?
|
Polycystic Ovary Syndrome | 3 | 2015 | 158 | 0.130 |
Why?
|
Suburban Population | 3 | 2006 | 17 | 0.130 |
Why?
|
Family Relations | 1 | 2016 | 88 | 0.130 |
Why?
|
National Institutes of Health (U.S.) | 6 | 2016 | 122 | 0.130 |
Why?
|
Physical Therapy Modalities | 1 | 2018 | 283 | 0.130 |
Why?
|
Thiophenes | 1 | 2016 | 108 | 0.130 |
Why?
|
Critical Care | 1 | 2020 | 563 | 0.130 |
Why?
|
Glucose | 2 | 2023 | 968 | 0.130 |
Why?
|
Decontamination | 3 | 2022 | 20 | 0.130 |
Why?
|
Colloids | 1 | 2015 | 60 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 2 | 2005 | 3264 | 0.130 |
Why?
|
Xenopus | 1 | 1995 | 108 | 0.130 |
Why?
|
Analgesics | 1 | 2016 | 163 | 0.130 |
Why?
|
Healthcare Disparities | 1 | 2020 | 494 | 0.130 |
Why?
|
Reye Syndrome | 2 | 1985 | 5 | 0.130 |
Why?
|
Models, Theoretical | 2 | 2009 | 574 | 0.130 |
Why?
|
Medical Informatics | 1 | 2016 | 108 | 0.130 |
Why?
|
Social Welfare | 1 | 2014 | 20 | 0.130 |
Why?
|
Analysis of Variance | 3 | 2013 | 1329 | 0.130 |
Why?
|
Recurrence | 3 | 2008 | 998 | 0.130 |
Why?
|
Interior Design and Furnishings | 1 | 2014 | 5 | 0.130 |
Why?
|
Salicylates | 2 | 1985 | 32 | 0.130 |
Why?
|
Menstrual Cycle | 2 | 2015 | 115 | 0.130 |
Why?
|
Silicon Dioxide | 1 | 2015 | 96 | 0.120 |
Why?
|
Blood Coagulation | 2 | 2014 | 226 | 0.120 |
Why?
|
Confidence Intervals | 4 | 2010 | 339 | 0.120 |
Why?
|
Eyelashes | 1 | 2014 | 3 | 0.120 |
Why?
|
Intergenerational Relations | 1 | 2014 | 16 | 0.120 |
Why?
|
Creatine | 2 | 1998 | 56 | 0.120 |
Why?
|
Cloprostenol | 1 | 2014 | 12 | 0.120 |
Why?
|
beta-Lactamases | 1 | 2014 | 26 | 0.120 |
Why?
|
Florida | 2 | 2013 | 77 | 0.120 |
Why?
|
Television | 2 | 2019 | 71 | 0.120 |
Why?
|
Platelet Count | 1 | 2014 | 85 | 0.120 |
Why?
|
Bacteriological Techniques | 1 | 2014 | 67 | 0.120 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 195 | 0.120 |
Why?
|
Learning | 1 | 2018 | 387 | 0.120 |
Why?
|
Continuity of Patient Care | 1 | 2016 | 276 | 0.120 |
Why?
|
Immunoassay | 2 | 2015 | 101 | 0.120 |
Why?
|
Family Practice | 3 | 2003 | 485 | 0.120 |
Why?
|
Infant Nutritional Physiological Phenomena | 2 | 2006 | 147 | 0.120 |
Why?
|
Nanoparticles | 2 | 2015 | 329 | 0.120 |
Why?
|
Executive Function | 1 | 2018 | 406 | 0.120 |
Why?
|
Ophthalmic Solutions | 1 | 2014 | 69 | 0.120 |
Why?
|
Phenotype | 3 | 2019 | 3070 | 0.120 |
Why?
|
Cognitive Dysfunction | 1 | 2018 | 309 | 0.120 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2014 | 40 | 0.120 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 230 | 0.120 |
Why?
|
Periodicals as Topic | 1 | 1997 | 239 | 0.120 |
Why?
|
Lipoproteins, HDL | 3 | 2016 | 82 | 0.120 |
Why?
|
Personality Inventory | 2 | 1997 | 137 | 0.120 |
Why?
|
Fibrinogen | 1 | 2014 | 162 | 0.120 |
Why?
|
Helium | 1 | 2013 | 8 | 0.120 |
Why?
|
Physicians, Women | 1 | 2014 | 53 | 0.120 |
Why?
|
Amides | 1 | 2014 | 88 | 0.120 |
Why?
|
Child Health Services | 2 | 2016 | 180 | 0.120 |
Why?
|
Combined Modality Therapy | 6 | 2017 | 1174 | 0.120 |
Why?
|
Tachycardia, Supraventricular | 1 | 1994 | 44 | 0.120 |
Why?
|
Alcoholic Intoxication | 1 | 1994 | 66 | 0.120 |
Why?
|
Fructose | 1 | 2015 | 204 | 0.120 |
Why?
|
Chronic Disease | 4 | 2017 | 1645 | 0.120 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 319 | 0.120 |
Why?
|
Surface-Active Agents | 2 | 2015 | 81 | 0.110 |
Why?
|
Administrative Personnel | 1 | 2013 | 35 | 0.110 |
Why?
|
Retinal Diseases | 4 | 2001 | 81 | 0.110 |
Why?
|
Hyperglycemia | 2 | 2014 | 326 | 0.110 |
Why?
|
Melatonin | 2 | 2004 | 110 | 0.110 |
Why?
|
Amines | 2 | 2010 | 41 | 0.110 |
Why?
|
Air | 1 | 2013 | 50 | 0.110 |
Why?
|
History, 21st Century | 2 | 2018 | 177 | 0.110 |
Why?
|
Health Personnel | 2 | 2013 | 603 | 0.110 |
Why?
|
Specimen Handling | 1 | 2014 | 169 | 0.110 |
Why?
|
Urban Health | 2 | 2012 | 89 | 0.110 |
Why?
|
Administration, Oral | 3 | 2012 | 786 | 0.110 |
Why?
|
Immunoglobulin G | 3 | 2015 | 804 | 0.110 |
Why?
|
Minerals | 1 | 2012 | 39 | 0.110 |
Why?
|
Practice Patterns, Physicians' | 2 | 2017 | 1267 | 0.110 |
Why?
|
Public Health Practice | 1 | 2013 | 61 | 0.110 |
Why?
|
Animals | 9 | 2019 | 34133 | 0.110 |
Why?
|
Coagulants | 1 | 2012 | 12 | 0.110 |
Why?
|
Plasma | 1 | 2014 | 223 | 0.110 |
Why?
|
Fellowships and Scholarships | 2 | 2015 | 255 | 0.110 |
Why?
|
Epidemiological Monitoring | 1 | 2012 | 50 | 0.110 |
Why?
|
Neoplasms | 4 | 2021 | 2235 | 0.110 |
Why?
|
Apolipoprotein A-I | 1 | 2012 | 27 | 0.110 |
Why?
|
Minority Groups | 2 | 2023 | 242 | 0.110 |
Why?
|
Factor VIII | 1 | 2012 | 56 | 0.110 |
Why?
|
Suburban Health | 1 | 2012 | 2 | 0.110 |
Why?
|
Blood Platelets | 2 | 2014 | 369 | 0.110 |
Why?
|
Blood Coagulation Tests | 1 | 2012 | 59 | 0.110 |
Why?
|
Cause of Death | 1 | 2014 | 389 | 0.110 |
Why?
|
National Health Programs | 1 | 2012 | 23 | 0.110 |
Why?
|
Mercury | 1 | 2012 | 31 | 0.110 |
Why?
|
Glycemic Index | 1 | 2012 | 24 | 0.110 |
Why?
|
Patient Education as Topic | 3 | 2012 | 717 | 0.110 |
Why?
|
Femoral Artery | 1 | 2013 | 182 | 0.110 |
Why?
|
Adenosine | 1 | 1994 | 212 | 0.110 |
Why?
|
Poverty | 1 | 2016 | 475 | 0.110 |
Why?
|
Coronary Artery Disease | 3 | 2011 | 695 | 0.100 |
Why?
|
Substance Withdrawal Syndrome | 1 | 1994 | 159 | 0.100 |
Why?
|
Precision Medicine | 1 | 2016 | 371 | 0.100 |
Why?
|
Ligation | 2 | 2009 | 83 | 0.100 |
Why?
|
Smoking Prevention | 1 | 2012 | 150 | 0.100 |
Why?
|
Hospital Departments | 1 | 2011 | 9 | 0.100 |
Why?
|
Cultural Diversity | 2 | 2023 | 59 | 0.100 |
Why?
|
Least-Squares Analysis | 2 | 2008 | 74 | 0.100 |
Why?
|
Observer Variation | 5 | 2012 | 314 | 0.100 |
Why?
|
Hostility | 2 | 2010 | 14 | 0.100 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2011 | 7 | 0.100 |
Why?
|
Blood Vessels | 2 | 2005 | 193 | 0.100 |
Why?
|
Household Products | 1 | 1991 | 6 | 0.100 |
Why?
|
Electrocardiography | 5 | 2009 | 620 | 0.100 |
Why?
|
Principal Component Analysis | 1 | 2012 | 186 | 0.100 |
Why?
|
Insulin-Secreting Cells | 1 | 2015 | 333 | 0.100 |
Why?
|
Infant, Premature | 2 | 1992 | 507 | 0.100 |
Why?
|
Health Planning Councils | 2 | 2008 | 6 | 0.100 |
Why?
|
Infection Control | 1 | 2012 | 138 | 0.100 |
Why?
|
Health Services Research | 1 | 2014 | 380 | 0.100 |
Why?
|
Detergents | 1 | 1991 | 46 | 0.100 |
Why?
|
Community Health Services | 1 | 2013 | 216 | 0.100 |
Why?
|
Household Articles | 1 | 1991 | 23 | 0.100 |
Why?
|
Erythrocytes | 2 | 1998 | 636 | 0.100 |
Why?
|
Calcinosis | 2 | 2011 | 292 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2012 | 242 | 0.100 |
Why?
|
Reactive Oxygen Species | 2 | 2024 | 592 | 0.100 |
Why?
|
Connective Tissue Diseases | 2 | 1994 | 58 | 0.100 |
Why?
|
Brain Ischemia | 2 | 2019 | 311 | 0.100 |
Why?
|
Obesity, Abdominal | 1 | 2010 | 39 | 0.100 |
Why?
|
Survivors | 2 | 2011 | 440 | 0.100 |
Why?
|
Cycloparaffins | 1 | 2010 | 2 | 0.100 |
Why?
|
Microchip Analytical Procedures | 1 | 2010 | 5 | 0.090 |
Why?
|
Environmental Exposure | 2 | 2011 | 427 | 0.090 |
Why?
|
Heart Atria | 2 | 2010 | 121 | 0.090 |
Why?
|
Postoperative Period | 3 | 2008 | 317 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2013 | 312 | 0.090 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2010 | 40 | 0.090 |
Why?
|
Polyenes | 1 | 2010 | 8 | 0.090 |
Why?
|
Patient-Centered Care | 1 | 2015 | 513 | 0.090 |
Why?
|
Attitude | 2 | 1989 | 236 | 0.090 |
Why?
|
Silver Sulfadiazine | 1 | 1989 | 1 | 0.090 |
Why?
|
Sulfadiazine | 1 | 1989 | 4 | 0.090 |
Why?
|
Electronic Health Records | 2 | 2017 | 842 | 0.090 |
Why?
|
Ethanol | 1 | 1994 | 584 | 0.090 |
Why?
|
Parenting | 1 | 2013 | 267 | 0.090 |
Why?
|
Dosage Forms | 1 | 2009 | 11 | 0.090 |
Why?
|
Dimethyl Sulfoxide | 1 | 1989 | 45 | 0.090 |
Why?
|
Acrylates | 1 | 1989 | 45 | 0.090 |
Why?
|
Basal Metabolism | 2 | 2002 | 50 | 0.090 |
Why?
|
Peritoneal Dialysis | 2 | 2001 | 86 | 0.090 |
Why?
|
Alcoholism | 2 | 2005 | 725 | 0.090 |
Why?
|
Epiphyses, Slipped | 1 | 2009 | 4 | 0.090 |
Why?
|
Staphylococcus aureus | 1 | 2013 | 400 | 0.090 |
Why?
|
Therapeutic Equivalency | 1 | 2009 | 17 | 0.090 |
Why?
|
Editorial Policies | 1 | 2010 | 53 | 0.090 |
Why?
|
Tooth, Impacted | 1 | 2009 | 9 | 0.090 |
Why?
|
Ventricular Function | 2 | 2000 | 61 | 0.090 |
Why?
|
Disinfectants | 2 | 2023 | 35 | 0.090 |
Why?
|
Oxygen | 2 | 2022 | 887 | 0.090 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2008 | 5 | 0.080 |
Why?
|
Atrial Function | 2 | 2006 | 11 | 0.080 |
Why?
|
Diet Therapy | 2 | 2017 | 38 | 0.080 |
Why?
|
Carotid Stenosis | 1 | 2009 | 80 | 0.080 |
Why?
|
Methacrylates | 1 | 1989 | 111 | 0.080 |
Why?
|
Sleep Apnea, Central | 1 | 2008 | 10 | 0.080 |
Why?
|
Anion Exchange Resins | 1 | 2008 | 8 | 0.080 |
Why?
|
Sample Size | 1 | 2009 | 135 | 0.080 |
Why?
|
Cyclooxygenase 2 | 1 | 2009 | 172 | 0.080 |
Why?
|
Anastomosis, Roux-en-Y | 2 | 2005 | 27 | 0.080 |
Why?
|
Homeostasis | 2 | 2009 | 596 | 0.080 |
Why?
|
Tobacco Smoke Pollution | 1 | 2011 | 235 | 0.080 |
Why?
|
Students | 2 | 2011 | 529 | 0.080 |
Why?
|
Niacin | 1 | 2008 | 20 | 0.080 |
Why?
|
Glucose Intolerance | 1 | 2010 | 140 | 0.080 |
Why?
|
Aged, 80 and over | 7 | 2013 | 6845 | 0.080 |
Why?
|
Pregnancy in Adolescence | 1 | 2009 | 77 | 0.080 |
Why?
|
Leadership | 1 | 2012 | 320 | 0.080 |
Why?
|
Arm | 2 | 2010 | 107 | 0.080 |
Why?
|
Diagnostic Errors | 2 | 2007 | 171 | 0.080 |
Why?
|
Microbial Viability | 2 | 2022 | 82 | 0.080 |
Why?
|
Health Care Costs | 1 | 2012 | 414 | 0.080 |
Why?
|
Drug Utilization | 1 | 2009 | 183 | 0.080 |
Why?
|
Publishing | 1 | 2010 | 161 | 0.080 |
Why?
|
Hypertension, Renovascular | 1 | 1987 | 16 | 0.080 |
Why?
|
Digestive System Diseases | 1 | 2008 | 26 | 0.080 |
Why?
|
Fatty Acids | 2 | 2001 | 410 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2012 | 392 | 0.080 |
Why?
|
Intracranial Hemorrhages | 1 | 2008 | 77 | 0.080 |
Why?
|
Culture | 1 | 2008 | 129 | 0.080 |
Why?
|
Dioxoles | 1 | 2007 | 9 | 0.080 |
Why?
|
Ifosfamide | 1 | 2007 | 31 | 0.080 |
Why?
|
Arousal | 2 | 2004 | 164 | 0.080 |
Why?
|
Hypothalamic Diseases | 1 | 2007 | 18 | 0.080 |
Why?
|
Signal Detection, Psychological | 1 | 2007 | 23 | 0.080 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2005 | 87 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2009 | 229 | 0.080 |
Why?
|
Oxygen Consumption | 1 | 2010 | 613 | 0.080 |
Why?
|
Anthracyclines | 1 | 2007 | 42 | 0.080 |
Why?
|
Cardiovascular Abnormalities | 1 | 2007 | 12 | 0.080 |
Why?
|
Prescription Drugs | 1 | 2009 | 113 | 0.080 |
Why?
|
Models, Animal | 1 | 2009 | 373 | 0.080 |
Why?
|
Cerebrovascular Disorders | 3 | 1982 | 91 | 0.080 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2007 | 70 | 0.080 |
Why?
|
Texas | 1 | 2007 | 195 | 0.080 |
Why?
|
Leg | 2 | 2010 | 249 | 0.070 |
Why?
|
Osteoporosis | 1 | 2010 | 234 | 0.070 |
Why?
|
Physical Examination | 1 | 2009 | 253 | 0.070 |
Why?
|
Endocardium | 2 | 1997 | 33 | 0.070 |
Why?
|
Perioperative Care | 2 | 2006 | 136 | 0.070 |
Why?
|
Echocardiography, Doppler | 4 | 1998 | 105 | 0.070 |
Why?
|
Syndrome | 2 | 2004 | 363 | 0.070 |
Why?
|
Informed Consent | 2 | 2006 | 166 | 0.070 |
Why?
|
Trace Elements | 1 | 2007 | 50 | 0.070 |
Why?
|
Craniopharyngioma | 1 | 2007 | 71 | 0.070 |
Why?
|
Pulsatile Flow | 3 | 2011 | 54 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 310 | 0.070 |
Why?
|
Compliance | 2 | 2004 | 44 | 0.070 |
Why?
|
Carrier Proteins | 2 | 2002 | 740 | 0.070 |
Why?
|
Kidney | 2 | 1994 | 1355 | 0.070 |
Why?
|
Urban Population | 3 | 2005 | 425 | 0.070 |
Why?
|
Seizures | 1 | 1989 | 360 | 0.070 |
Why?
|
Drinking Behavior | 1 | 2006 | 11 | 0.070 |
Why?
|
Healthy People Programs | 1 | 2006 | 8 | 0.070 |
Why?
|
Drug Therapy, Combination | 2 | 2008 | 988 | 0.070 |
Why?
|
Mitral Valve | 2 | 2005 | 94 | 0.070 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2006 | 26 | 0.070 |
Why?
|
Publication Bias | 1 | 2006 | 39 | 0.070 |
Why?
|
Waiting Lists | 1 | 2008 | 229 | 0.070 |
Why?
|
Pituitary Neoplasms | 1 | 2007 | 166 | 0.070 |
Why?
|
Virginia | 1 | 2005 | 52 | 0.070 |
Why?
|
Polymers | 1 | 2010 | 475 | 0.070 |
Why?
|
Peer Review, Research | 1 | 2006 | 43 | 0.070 |
Why?
|
Epidemiologic Studies | 1 | 2005 | 63 | 0.070 |
Why?
|
Inflammation | 3 | 2012 | 2598 | 0.070 |
Why?
|
Sarcoma | 1 | 2007 | 138 | 0.070 |
Why?
|
Social Adjustment | 1 | 2005 | 54 | 0.070 |
Why?
|
Psychology, Social | 1 | 2005 | 10 | 0.070 |
Why?
|
Infant Food | 1 | 2006 | 72 | 0.070 |
Why?
|
Social Environment | 1 | 2007 | 301 | 0.070 |
Why?
|
Cardiac Volume | 1 | 2005 | 12 | 0.070 |
Why?
|
Sulfones | 2 | 2003 | 102 | 0.070 |
Why?
|
Body Weights and Measures | 1 | 2005 | 37 | 0.070 |
Why?
|
Program Development | 1 | 2007 | 372 | 0.070 |
Why?
|
Serum Amyloid A Protein | 1 | 2005 | 28 | 0.070 |
Why?
|
Psychology | 1 | 2005 | 85 | 0.070 |
Why?
|
Adenoids | 1 | 2004 | 9 | 0.070 |
Why?
|
Tonsillitis | 1 | 2004 | 7 | 0.070 |
Why?
|
Hypercalcemia | 1 | 1985 | 22 | 0.070 |
Why?
|
Dietary Fiber | 1 | 2005 | 46 | 0.060 |
Why?
|
Educational Measurement | 2 | 2015 | 298 | 0.060 |
Why?
|
Hospitals, Pediatric | 3 | 2005 | 507 | 0.060 |
Why?
|
Drug Therapy | 1 | 2005 | 75 | 0.060 |
Why?
|
Amlodipine | 1 | 2004 | 8 | 0.060 |
Why?
|
Musculoskeletal Diseases | 1 | 2006 | 74 | 0.060 |
Why?
|
Reward | 2 | 2018 | 214 | 0.060 |
Why?
|
Polyethylene Glycols | 1 | 1989 | 560 | 0.060 |
Why?
|
Personality Assessment | 1 | 2004 | 83 | 0.060 |
Why?
|
Hyperphagia | 1 | 2004 | 32 | 0.060 |
Why?
|
Respiratory Tract Diseases | 1 | 2006 | 140 | 0.060 |
Why?
|
Milk, Human | 1 | 2006 | 149 | 0.060 |
Why?
|
Cardiomegaly | 3 | 1991 | 168 | 0.060 |
Why?
|
Aortic Valve Stenosis | 2 | 1988 | 315 | 0.060 |
Why?
|
Parental Consent | 1 | 2004 | 23 | 0.060 |
Why?
|
Internal-External Control | 1 | 2004 | 73 | 0.060 |
Why?
|
Likelihood Functions | 1 | 2004 | 139 | 0.060 |
Why?
|
Mental Competency | 1 | 2004 | 26 | 0.060 |
Why?
|
Factor Analysis, Statistical | 1 | 2005 | 283 | 0.060 |
Why?
|
Oxyhemoglobins | 1 | 2004 | 19 | 0.060 |
Why?
|
Respiration Disorders | 1 | 2004 | 67 | 0.060 |
Why?
|
Haplotypes | 1 | 2006 | 482 | 0.060 |
Why?
|
Extracorporeal Membrane Oxygenation | 3 | 1993 | 249 | 0.060 |
Why?
|
Heart Function Tests | 1 | 2004 | 68 | 0.060 |
Why?
|
Calcium Channel Blockers | 1 | 2004 | 121 | 0.060 |
Why?
|
Twins | 1 | 2005 | 247 | 0.060 |
Why?
|
Blood Gas Analysis | 1 | 2004 | 79 | 0.060 |
Why?
|
Colony Count, Microbial | 2 | 2015 | 124 | 0.060 |
Why?
|
Smoke | 1 | 2005 | 146 | 0.060 |
Why?
|
Nutritional Physiological Phenomena | 2 | 2001 | 55 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2004 | 102 | 0.060 |
Why?
|
Sampling Studies | 2 | 2000 | 95 | 0.060 |
Why?
|
Temperament | 1 | 2004 | 68 | 0.060 |
Why?
|
Dyspepsia | 1 | 2003 | 9 | 0.060 |
Why?
|
Reactive Nitrogen Species | 1 | 2023 | 27 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2011 | 929 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 242 | 0.060 |
Why?
|
Creatinine | 2 | 2022 | 510 | 0.060 |
Why?
|
Fractures, Bone | 1 | 2009 | 378 | 0.060 |
Why?
|
Renin | 2 | 1993 | 36 | 0.060 |
Why?
|
General Surgery | 1 | 2005 | 146 | 0.060 |
Why?
|
Mental Disorders | 2 | 2005 | 952 | 0.060 |
Why?
|
Mother-Child Relations | 1 | 2004 | 123 | 0.060 |
Why?
|
Epidemiology | 1 | 1983 | 16 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2005 | 373 | 0.060 |
Why?
|
Air Microbiology | 1 | 2023 | 42 | 0.060 |
Why?
|
Contraception | 2 | 2011 | 123 | 0.060 |
Why?
|
Isoquinolines | 1 | 2003 | 42 | 0.060 |
Why?
|
ROC Curve | 2 | 2011 | 494 | 0.060 |
Why?
|
Community Health Planning | 1 | 2003 | 40 | 0.060 |
Why?
|
Cardiomyopathy, Dilated | 2 | 1999 | 349 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 839 | 0.060 |
Why?
|
Delayed-Action Preparations | 2 | 2016 | 162 | 0.060 |
Why?
|
Goals | 2 | 2015 | 167 | 0.050 |
Why?
|
Lipoprotein(a) | 1 | 2022 | 49 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2006 | 347 | 0.050 |
Why?
|
Analgesia | 1 | 2003 | 82 | 0.050 |
Why?
|
Intracranial Arteriosclerosis | 1 | 1982 | 8 | 0.050 |
Why?
|
Infant, Premature, Diseases | 1 | 1984 | 97 | 0.050 |
Why?
|
Self-Help Groups | 2 | 2005 | 33 | 0.050 |
Why?
|
Faculty | 1 | 2023 | 133 | 0.050 |
Why?
|
Educational Status | 4 | 2006 | 448 | 0.050 |
Why?
|
Ocular Hypotension | 1 | 2001 | 11 | 0.050 |
Why?
|
Iowa | 1 | 2021 | 27 | 0.050 |
Why?
|
Albumins | 1 | 2022 | 104 | 0.050 |
Why?
|
Ciliary Body | 1 | 2001 | 34 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2004 | 601 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2014 | 416 | 0.050 |
Why?
|
Models, Biological | 1 | 2009 | 1756 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2021 | 44 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2005 | 510 | 0.050 |
Why?
|
Eye Injuries | 1 | 2001 | 46 | 0.050 |
Why?
|
Hypertrichosis | 1 | 2001 | 6 | 0.050 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 1991 | 43 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 2 | 2018 | 2501 | 0.050 |
Why?
|
Lip | 1 | 2001 | 22 | 0.050 |
Why?
|
Membrane Transport Proteins | 1 | 2002 | 137 | 0.050 |
Why?
|
Gravidity | 2 | 2011 | 8 | 0.050 |
Why?
|
Nutritional Sciences | 1 | 2001 | 36 | 0.050 |
Why?
|
Osteotomy | 1 | 2022 | 158 | 0.050 |
Why?
|
Health | 1 | 2001 | 81 | 0.050 |
Why?
|
Curriculum | 3 | 2015 | 925 | 0.050 |
Why?
|
Registries | 2 | 2007 | 2020 | 0.050 |
Why?
|
Religion and Psychology | 1 | 1980 | 28 | 0.050 |
Why?
|
Hair | 1 | 2001 | 70 | 0.050 |
Why?
|
Rest | 2 | 1994 | 112 | 0.050 |
Why?
|
Rats | 1 | 2009 | 5426 | 0.050 |
Why?
|
Bacteria, Aerobic | 1 | 2020 | 7 | 0.050 |
Why?
|
Cataract Extraction | 1 | 2001 | 82 | 0.050 |
Why?
|
Parity | 2 | 2011 | 108 | 0.050 |
Why?
|
Vietnam | 1 | 2000 | 23 | 0.050 |
Why?
|
Biofilms | 1 | 2022 | 236 | 0.050 |
Why?
|
Mississippi | 1 | 2000 | 19 | 0.050 |
Why?
|
Water | 1 | 2023 | 433 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2024 | 915 | 0.050 |
Why?
|
Attitude to Death | 1 | 1980 | 61 | 0.050 |
Why?
|
Mitochondrial Proteins | 1 | 2002 | 231 | 0.050 |
Why?
|
Medicaid | 1 | 2004 | 416 | 0.050 |
Why?
|
Gastric Emptying | 1 | 2000 | 40 | 0.050 |
Why?
|
Visual Acuity | 1 | 2001 | 275 | 0.050 |
Why?
|
Culturally Competent Care | 1 | 2020 | 56 | 0.050 |
Why?
|
Pyridines | 1 | 2003 | 440 | 0.050 |
Why?
|
Stomach | 1 | 2000 | 109 | 0.040 |
Why?
|
Association | 1 | 2019 | 11 | 0.040 |
Why?
|
Homocysteine | 1 | 1999 | 138 | 0.040 |
Why?
|
Estrogen Replacement Therapy | 1 | 2000 | 118 | 0.040 |
Why?
|
Lactones | 1 | 1999 | 57 | 0.040 |
Why?
|
Breast | 2 | 2003 | 141 | 0.040 |
Why?
|
Polyradiculoneuropathy | 1 | 1998 | 3 | 0.040 |
Why?
|
Purine-Pyrimidine Metabolism, Inborn Errors | 1 | 1998 | 2 | 0.040 |
Why?
|
Dimensional Measurement Accuracy | 1 | 2018 | 12 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2018 | 2720 | 0.040 |
Why?
|
Adenosine Deaminase | 1 | 1998 | 26 | 0.040 |
Why?
|
Severe Combined Immunodeficiency | 1 | 1998 | 21 | 0.040 |
Why?
|
Cardiopulmonary Bypass | 2 | 1998 | 213 | 0.040 |
Why?
|
Neuropharmacology | 1 | 2018 | 4 | 0.040 |
Why?
|
Switzerland | 1 | 2018 | 27 | 0.040 |
Why?
|
Exercise Therapy | 2 | 2017 | 375 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2000 | 226 | 0.040 |
Why?
|
Education | 1 | 2019 | 110 | 0.040 |
Why?
|
England | 1 | 2018 | 72 | 0.040 |
Why?
|
Oxidative Stress | 2 | 2008 | 1204 | 0.040 |
Why?
|
Fluorescein Angiography | 2 | 2001 | 103 | 0.040 |
Why?
|
Endothelins | 1 | 2018 | 62 | 0.040 |
Why?
|
Metabolic Clearance Rate | 2 | 2012 | 111 | 0.040 |
Why?
|
Postmenopause | 1 | 2000 | 307 | 0.040 |
Why?
|
Half-Life | 2 | 2012 | 147 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 1 | 1998 | 92 | 0.040 |
Why?
|
Liver Diseases | 1 | 2001 | 325 | 0.040 |
Why?
|
Self Administration | 1 | 2018 | 125 | 0.040 |
Why?
|
Occupational Health | 2 | 2013 | 175 | 0.040 |
Why?
|
Glycemic Load | 1 | 2017 | 1 | 0.040 |
Why?
|
Lipoproteins, LDL | 3 | 2008 | 138 | 0.040 |
Why?
|
Area Under Curve | 2 | 2012 | 303 | 0.040 |
Why?
|
Attitude of Health Personnel | 2 | 2017 | 1012 | 0.040 |
Why?
|
Edible Grain | 2 | 2012 | 45 | 0.040 |
Why?
|
Sulfhydryl Compounds | 1 | 1999 | 190 | 0.040 |
Why?
|
Morphine | 2 | 2016 | 137 | 0.040 |
Why?
|
Random Allocation | 1 | 2018 | 360 | 0.040 |
Why?
|
Liver | 3 | 2015 | 1827 | 0.040 |
Why?
|
Rheumatic Diseases | 1 | 1997 | 49 | 0.040 |
Why?
|
Tablets | 1 | 2016 | 39 | 0.040 |
Why?
|
Cholestyramine Resin | 1 | 1996 | 7 | 0.040 |
Why?
|
Munchausen Syndrome by Proxy | 1 | 1996 | 2 | 0.040 |
Why?
|
Ipecac | 1 | 1996 | 8 | 0.040 |
Why?
|
Contraindications | 2 | 2007 | 102 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 1999 | 931 | 0.040 |
Why?
|
Sodium Chloride | 1 | 1997 | 154 | 0.040 |
Why?
|
Norepinephrine | 2 | 1987 | 214 | 0.040 |
Why?
|
Specialty Boards | 1 | 2016 | 43 | 0.040 |
Why?
|
Self-Control | 1 | 2017 | 55 | 0.040 |
Why?
|
Gastrointestinal Agents | 1 | 2017 | 61 | 0.040 |
Why?
|
Automation | 1 | 1996 | 79 | 0.040 |
Why?
|
Equipment Design | 2 | 2010 | 533 | 0.040 |
Why?
|
Surgical Flaps | 1 | 1997 | 119 | 0.040 |
Why?
|
Minority Health | 1 | 2016 | 19 | 0.030 |
Why?
|
Rural Population | 1 | 2000 | 482 | 0.030 |
Why?
|
Dietary Proteins | 2 | 2011 | 131 | 0.030 |
Why?
|
Selection Bias | 1 | 1995 | 35 | 0.030 |
Why?
|
Drug Interactions | 1 | 1997 | 356 | 0.030 |
Why?
|
Proteins | 1 | 2002 | 953 | 0.030 |
Why?
|
Light | 2 | 2015 | 346 | 0.030 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2015 | 6 | 0.030 |
Why?
|
Nuclear Transfer Techniques | 1 | 1995 | 2 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 836 | 0.030 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 2015 | 21 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 551 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2002 | 1093 | 0.030 |
Why?
|
Patients' Rooms | 1 | 2015 | 15 | 0.030 |
Why?
|
Physicians' Offices | 1 | 1995 | 17 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2015 | 76 | 0.030 |
Why?
|
Polysorbates | 1 | 2015 | 35 | 0.030 |
Why?
|
Anemia, Sickle Cell | 2 | 2008 | 226 | 0.030 |
Why?
|
Ankle Brachial Index | 1 | 2015 | 32 | 0.030 |
Why?
|
Professional-Patient Relations | 1 | 2016 | 146 | 0.030 |
Why?
|
Hyperlipoproteinemias | 2 | 2007 | 6 | 0.030 |
Why?
|
Scattering, Radiation | 1 | 2015 | 95 | 0.030 |
Why?
|
Freeze Drying | 1 | 2015 | 76 | 0.030 |
Why?
|
Serum Albumin, Bovine | 1 | 2015 | 69 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2005 | 2500 | 0.030 |
Why?
|
Growth | 1 | 1995 | 60 | 0.030 |
Why?
|
Reoperation | 1 | 1997 | 570 | 0.030 |
Why?
|
Tobacco Products | 1 | 2016 | 74 | 0.030 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2015 | 48 | 0.030 |
Why?
|
Elective Surgical Procedures | 1 | 2016 | 165 | 0.030 |
Why?
|
Lipid Metabolism | 2 | 2010 | 482 | 0.030 |
Why?
|
Receptors, Dopamine D2 | 1 | 2015 | 88 | 0.030 |
Why?
|
Breast Diseases | 1 | 1994 | 19 | 0.030 |
Why?
|
Drug Prescriptions | 1 | 2017 | 271 | 0.030 |
Why?
|
Cholesterol, Dietary | 2 | 2007 | 16 | 0.030 |
Why?
|
Thrombopoiesis | 1 | 2014 | 7 | 0.030 |
Why?
|
Behavior, Addictive | 1 | 2015 | 79 | 0.030 |
Why?
|
Methicillin Resistance | 1 | 2014 | 19 | 0.030 |
Why?
|
Immunization | 1 | 1997 | 421 | 0.030 |
Why?
|
Mutation | 2 | 2011 | 3493 | 0.030 |
Why?
|
Lymphoscintigraphy | 1 | 1994 | 8 | 0.030 |
Why?
|
Bimatoprost | 1 | 2014 | 3 | 0.030 |
Why?
|
Quinolines | 1 | 2015 | 127 | 0.030 |
Why?
|
Nonverbal Communication | 1 | 1994 | 4 | 0.030 |
Why?
|
Fontan Procedure | 1 | 1996 | 155 | 0.030 |
Why?
|
Ventricular Function, Right | 1 | 1996 | 262 | 0.030 |
Why?
|
Mice | 2 | 2009 | 15888 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2015 | 370 | 0.030 |
Why?
|
Esthetics | 1 | 2014 | 37 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 1562 | 0.030 |
Why?
|
Particle Size | 1 | 2015 | 344 | 0.030 |
Why?
|
DNA Methylation | 1 | 2018 | 511 | 0.030 |
Why?
|
Heart Block | 1 | 1994 | 41 | 0.030 |
Why?
|
Quality Control | 1 | 2014 | 165 | 0.030 |
Why?
|
Anxiety | 1 | 1980 | 888 | 0.030 |
Why?
|
Capsules | 1 | 2013 | 37 | 0.030 |
Why?
|
Visual Analog Scale | 1 | 2013 | 34 | 0.030 |
Why?
|
International Cooperation | 1 | 2014 | 182 | 0.030 |
Why?
|
Taste | 1 | 1996 | 227 | 0.030 |
Why?
|
DNA Replication | 1 | 1995 | 214 | 0.030 |
Why?
|
Writing | 1 | 2015 | 90 | 0.030 |
Why?
|
Gene Expression | 2 | 1998 | 1506 | 0.030 |
Why?
|
Biomedical Technology | 1 | 2014 | 45 | 0.030 |
Why?
|
Length of Stay | 2 | 1998 | 1077 | 0.030 |
Why?
|
Glass | 1 | 2013 | 45 | 0.030 |
Why?
|
Canada | 2 | 2008 | 355 | 0.030 |
Why?
|
Bacterial Load | 1 | 2013 | 69 | 0.030 |
Why?
|
Catecholamines | 1 | 1993 | 103 | 0.030 |
Why?
|
Cardiac Output, Low | 1 | 1993 | 78 | 0.030 |
Why?
|
Interleukin-2 | 1 | 1994 | 420 | 0.030 |
Why?
|
Anesthesia, General | 1 | 1993 | 51 | 0.030 |
Why?
|
Debridement | 1 | 1993 | 78 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2004 | 314 | 0.030 |
Why?
|
Genetic Carrier Screening | 1 | 2012 | 26 | 0.030 |
Why?
|
Fibromyalgia | 1 | 1993 | 58 | 0.030 |
Why?
|
International System of Units | 1 | 2012 | 2 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 1996 | 308 | 0.030 |
Why?
|
Coronary Vessel Anomalies | 2 | 1991 | 31 | 0.030 |
Why?
|
Teaching | 1 | 2015 | 241 | 0.030 |
Why?
|
Clinical Clerkship | 1 | 1994 | 99 | 0.030 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1992 | 46 | 0.030 |
Why?
|
Survival Analysis | 2 | 2010 | 1325 | 0.030 |
Why?
|
Transferrin | 1 | 1992 | 36 | 0.030 |
Why?
|
Aspirin | 2 | 2003 | 344 | 0.030 |
Why?
|
Catheterization | 1 | 1993 | 165 | 0.030 |
Why?
|
Poultry | 1 | 2012 | 12 | 0.030 |
Why?
|
Alpha-Globulins | 1 | 1992 | 21 | 0.030 |
Why?
|
Fathers | 1 | 2012 | 47 | 0.030 |
Why?
|
Hyaluronic Acid | 1 | 1994 | 203 | 0.030 |
Why?
|
Cell Cycle | 1 | 1995 | 584 | 0.030 |
Why?
|
Cardiac Catheterization | 3 | 1991 | 577 | 0.030 |
Why?
|
Hot Temperature | 2 | 2010 | 345 | 0.030 |
Why?
|
Interleukin-6 | 2 | 2012 | 702 | 0.030 |
Why?
|
Absorption | 1 | 2012 | 56 | 0.030 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2005 | 770 | 0.030 |
Why?
|
Career Choice | 1 | 2014 | 206 | 0.030 |
Why?
|
Calibration | 1 | 2012 | 140 | 0.030 |
Why?
|
Digoxin | 1 | 1991 | 29 | 0.030 |
Why?
|
Cell Nucleus | 1 | 1995 | 598 | 0.030 |
Why?
|
Biopsy | 2 | 2006 | 1090 | 0.030 |
Why?
|
Income | 2 | 2003 | 181 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2013 | 152 | 0.030 |
Why?
|
Fishes | 1 | 2012 | 85 | 0.030 |
Why?
|
Pulse | 2 | 2006 | 30 | 0.030 |
Why?
|
MicroRNAs | 1 | 2018 | 661 | 0.030 |
Why?
|
Magnesium | 2 | 2007 | 156 | 0.030 |
Why?
|
Causality | 1 | 2012 | 115 | 0.030 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2012 | 108 | 0.030 |
Why?
|
Isoenzymes | 1 | 1992 | 303 | 0.030 |
Why?
|
Social Responsibility | 1 | 2012 | 51 | 0.030 |
Why?
|
Evaluation Studies as Topic | 3 | 1993 | 190 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 1625 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2012 | 312 | 0.030 |
Why?
|
Societies | 1 | 2011 | 42 | 0.030 |
Why?
|
2-Hydroxypropyl-beta-cyclodextrin | 1 | 2011 | 6 | 0.020 |
Why?
|
Hyperaldosteronism | 1 | 2011 | 8 | 0.020 |
Why?
|
Fundus Oculi | 1 | 1991 | 41 | 0.020 |
Why?
|
Inservice Training | 1 | 2012 | 105 | 0.020 |
Why?
|
Proprotein Convertases | 1 | 2011 | 14 | 0.020 |
Why?
|
Albuminuria | 1 | 1992 | 195 | 0.020 |
Why?
|
Gestational Age | 2 | 2011 | 787 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2011 | 168 | 0.020 |
Why?
|
Leptin | 1 | 2012 | 233 | 0.020 |
Why?
|
beta-Cyclodextrins | 1 | 2011 | 32 | 0.020 |
Why?
|
Actigraphy | 1 | 2011 | 102 | 0.020 |
Why?
|
Homozygote | 1 | 2011 | 192 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2011 | 104 | 0.020 |
Why?
|
Emotions | 1 | 2016 | 524 | 0.020 |
Why?
|
Ethylenediamines | 1 | 2010 | 7 | 0.020 |
Why?
|
Wettability | 1 | 2010 | 14 | 0.020 |
Why?
|
Propylamines | 1 | 2010 | 12 | 0.020 |
Why?
|
Photography | 1 | 1991 | 96 | 0.020 |
Why?
|
Silanes | 1 | 2010 | 20 | 0.020 |
Why?
|
Food Handling | 1 | 2010 | 51 | 0.020 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2010 | 88 | 0.020 |
Why?
|
Sign Language | 1 | 1989 | 3 | 0.020 |
Why?
|
Diagnosis, Differential | 4 | 2005 | 1423 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2010 | 26 | 0.020 |
Why?
|
Type A Personality | 1 | 1989 | 2 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2010 | 205 | 0.020 |
Why?
|
New York City | 2 | 2004 | 78 | 0.020 |
Why?
|
Italy | 2 | 2004 | 95 | 0.020 |
Why?
|
Vaccines | 1 | 1995 | 384 | 0.020 |
Why?
|
Schools, Medical | 1 | 2011 | 152 | 0.020 |
Why?
|
Cooking | 1 | 2010 | 52 | 0.020 |
Why?
|
Organizational Objectives | 1 | 2010 | 68 | 0.020 |
Why?
|
Adhesiveness | 1 | 1989 | 19 | 0.020 |
Why?
|
Gases | 1 | 2010 | 50 | 0.020 |
Why?
|
Occlusive Dressings | 1 | 1989 | 5 | 0.020 |
Why?
|
Environment | 1 | 2012 | 357 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2014 | 632 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1989 | 82 | 0.020 |
Why?
|
Heart Septum | 2 | 2004 | 28 | 0.020 |
Why?
|
Oscillometry | 1 | 2009 | 36 | 0.020 |
Why?
|
Manometry | 1 | 2009 | 89 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2010 | 142 | 0.020 |
Why?
|
Malnutrition | 1 | 2010 | 69 | 0.020 |
Why?
|
Risk Management | 1 | 2010 | 94 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2009 | 105 | 0.020 |
Why?
|
DNA, Single-Stranded | 1 | 2010 | 114 | 0.020 |
Why?
|
Students, Medical | 1 | 1994 | 328 | 0.020 |
Why?
|
Fistula | 1 | 1989 | 27 | 0.020 |
Why?
|
South Carolina | 1 | 2008 | 37 | 0.020 |
Why?
|
Voluntary Health Agencies | 1 | 2008 | 6 | 0.020 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2008 | 31 | 0.020 |
Why?
|
Professional Staff Committees | 1 | 2008 | 12 | 0.020 |
Why?
|
Atrial Natriuretic Factor | 1 | 1988 | 59 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 1994 | 475 | 0.020 |
Why?
|
Hemoglobins | 2 | 1989 | 293 | 0.020 |
Why?
|
Moyamoya Disease | 1 | 2008 | 15 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 1992 | 292 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2014 | 543 | 0.020 |
Why?
|
Intracranial Embolism | 1 | 2008 | 27 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 2491 | 0.020 |
Why?
|
Aortic Stenosis, Subvalvular | 1 | 1988 | 4 | 0.020 |
Why?
|
Nutrition Therapy | 1 | 2008 | 33 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2016 | 635 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 884 | 0.020 |
Why?
|
Education, Medical, Undergraduate | 1 | 2011 | 204 | 0.020 |
Why?
|
Georgia | 1 | 1988 | 62 | 0.020 |
Why?
|
Fibromuscular Dysplasia | 1 | 1987 | 4 | 0.020 |
Why?
|
Psychometrics | 2 | 1989 | 672 | 0.020 |
Why?
|
Pulmonary Veins | 1 | 1989 | 97 | 0.020 |
Why?
|
Physical Exertion | 1 | 1989 | 231 | 0.020 |
Why?
|
Risk-Taking | 1 | 2010 | 334 | 0.020 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 1989 | 132 | 0.020 |
Why?
|
Failure to Thrive | 1 | 1987 | 30 | 0.020 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2008 | 68 | 0.020 |
Why?
|
Medical Audit | 1 | 2008 | 78 | 0.020 |
Why?
|
Arteritis | 1 | 1987 | 27 | 0.020 |
Why?
|
Hypopituitarism | 1 | 2007 | 15 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2009 | 214 | 0.020 |
Why?
|
Neurofibromatosis 1 | 1 | 1987 | 37 | 0.020 |
Why?
|
Nutritive Value | 1 | 2007 | 30 | 0.020 |
Why?
|
Sympathetic Nervous System | 1 | 2008 | 173 | 0.020 |
Why?
|
Vitamin A | 1 | 2007 | 55 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2010 | 410 | 0.020 |
Why?
|
Nursing | 1 | 2007 | 33 | 0.020 |
Why?
|
Melanoma | 1 | 1994 | 709 | 0.020 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 1988 | 122 | 0.020 |
Why?
|
Interpersonal Relations | 2 | 2006 | 351 | 0.020 |
Why?
|
HIV Protease Inhibitors | 1 | 2007 | 65 | 0.020 |
Why?
|
Phytotherapy | 1 | 2007 | 72 | 0.020 |
Why?
|
Angioplasty, Balloon | 1 | 1987 | 92 | 0.020 |
Why?
|
Mass Media | 1 | 2006 | 38 | 0.020 |
Why?
|
United Kingdom | 1 | 2007 | 260 | 0.020 |
Why?
|
Databases, Factual | 1 | 2012 | 1287 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 2008 | 213 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2007 | 178 | 0.020 |
Why?
|
Tachycardia | 1 | 2006 | 57 | 0.020 |
Why?
|
Fetal Diseases | 1 | 2007 | 149 | 0.020 |
Why?
|
Aneurysm | 1 | 1986 | 33 | 0.020 |
Why?
|
Hepatitis | 1 | 2006 | 48 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2008 | 310 | 0.020 |
Why?
|
Blotting, Western | 1 | 2008 | 1225 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2007 | 661 | 0.020 |
Why?
|
DNA | 1 | 1992 | 1401 | 0.020 |
Why?
|
Consensus | 1 | 2008 | 554 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 1987 | 183 | 0.020 |
Why?
|
Retinal Artery | 1 | 1985 | 15 | 0.020 |
Why?
|
Panic Disorder | 1 | 2005 | 23 | 0.020 |
Why?
|
Phobic Disorders | 1 | 2005 | 29 | 0.020 |
Why?
|
Achievement | 1 | 2005 | 56 | 0.020 |
Why?
|
Cerebral Angiography | 2 | 1982 | 116 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 1376 | 0.020 |
Why?
|
Cotinine | 1 | 2005 | 78 | 0.020 |
Why?
|
Renal Artery Obstruction | 1 | 1985 | 32 | 0.020 |
Why?
|
Workplace | 1 | 2006 | 225 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 2005 | 41 | 0.020 |
Why?
|
Genotype | 2 | 2002 | 1943 | 0.020 |
Why?
|
Food Services | 1 | 2004 | 20 | 0.020 |
Why?
|
Radiography | 1 | 1987 | 888 | 0.020 |
Why?
|
Sutures | 1 | 2005 | 63 | 0.020 |
Why?
|
Child Care | 1 | 2004 | 27 | 0.020 |
Why?
|
Physical Education and Training | 1 | 2004 | 61 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2006 | 248 | 0.020 |
Why?
|
Aortic Valve Insufficiency | 1 | 2004 | 45 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2005 | 247 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2006 | 235 | 0.020 |
Why?
|
Mexican Americans | 1 | 2005 | 100 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2006 | 252 | 0.010 |
Why?
|
Free Radical Scavengers | 1 | 2004 | 90 | 0.010 |
Why?
|
Physical Endurance | 1 | 2005 | 234 | 0.010 |
Why?
|
Vitamin D | 1 | 2007 | 363 | 0.010 |
Why?
|
Anticoagulants | 1 | 2008 | 589 | 0.010 |
Why?
|
Aortic Diseases | 1 | 1985 | 95 | 0.010 |
Why?
|
Stomach Diseases | 1 | 2003 | 20 | 0.010 |
Why?
|
Peptic Ulcer | 1 | 2003 | 15 | 0.010 |
Why?
|
Helicobacter Infections | 1 | 2003 | 25 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 1989 | 707 | 0.010 |
Why?
|
Helicobacter pylori | 1 | 2003 | 32 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2007 | 473 | 0.010 |
Why?
|
Face | 1 | 1985 | 179 | 0.010 |
Why?
|
Genitalia, Female | 1 | 2003 | 40 | 0.010 |
Why?
|
Wakefulness | 1 | 2004 | 141 | 0.010 |
Why?
|
Biological Availability | 1 | 2003 | 129 | 0.010 |
Why?
|
Esophagitis | 1 | 2003 | 67 | 0.010 |
Why?
|
Publications | 1 | 2003 | 42 | 0.010 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2003 | 62 | 0.010 |
Why?
|
Preoperative Care | 1 | 2005 | 342 | 0.010 |
Why?
|
Uncoupling Protein 3 | 1 | 2002 | 9 | 0.010 |
Why?
|
Uncoupling Protein 1 | 1 | 2002 | 17 | 0.010 |
Why?
|
Uncoupling Protein 2 | 1 | 2002 | 7 | 0.010 |
Why?
|
Calorimetry, Indirect | 1 | 2002 | 75 | 0.010 |
Why?
|
Testosterone | 1 | 2005 | 353 | 0.010 |
Why?
|
Hypoxia | 1 | 2008 | 1003 | 0.010 |
Why?
|
Ion Channels | 1 | 2002 | 130 | 0.010 |
Why?
|
Laser Coagulation | 1 | 2001 | 58 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2003 | 228 | 0.010 |
Why?
|
Lens Implantation, Intraocular | 1 | 2001 | 60 | 0.010 |
Why?
|
Fish Oils | 1 | 2001 | 26 | 0.010 |
Why?
|
Plant Oils | 1 | 2001 | 28 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 1188 | 0.010 |
Why?
|
Fish Products | 1 | 2000 | 1 | 0.010 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2003 | 207 | 0.010 |
Why?
|
Women's Health | 1 | 2003 | 277 | 0.010 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2000 | 22 | 0.010 |
Why?
|
Barrett Esophagus | 1 | 2003 | 159 | 0.010 |
Why?
|
Coronary Angiography | 3 | 1989 | 336 | 0.010 |
Why?
|
Software | 1 | 2005 | 631 | 0.010 |
Why?
|
Hemostasis | 1 | 2001 | 72 | 0.010 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 2000 | 7 | 0.010 |
Why?
|
Tropomodulin | 1 | 1999 | 2 | 0.010 |
Why?
|
North Carolina | 1 | 2000 | 116 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2000 | 134 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2004 | 462 | 0.010 |
Why?
|
Mental Health | 1 | 2005 | 571 | 0.010 |
Why?
|
Intraocular Pressure | 1 | 2001 | 286 | 0.010 |
Why?
|
Medical Records | 1 | 2000 | 181 | 0.010 |
Why?
|
Immunoblotting | 1 | 1999 | 318 | 0.010 |
Why?
|
Adenine Nucleotides | 1 | 1998 | 20 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 1999 | 135 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2000 | 196 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 1998 | 56 | 0.010 |
Why?
|
Louisiana | 1 | 1998 | 26 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2006 | 985 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2006 | 2127 | 0.010 |
Why?
|
Body Surface Area | 1 | 1997 | 28 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2005 | 813 | 0.010 |
Why?
|
Pedigree | 2 | 1992 | 492 | 0.010 |
Why?
|
Emetine | 1 | 1996 | 3 | 0.010 |
Why?
|
Thermometers | 1 | 1995 | 6 | 0.010 |
Why?
|
Alleles | 1 | 1998 | 852 | 0.010 |
Why?
|
Refrigeration | 1 | 1995 | 11 | 0.010 |
Why?
|
Medical Staff | 1 | 1995 | 16 | 0.010 |
Why?
|
Group Practice | 1 | 1995 | 13 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 1556 | 0.010 |
Why?
|
Private Practice | 1 | 1995 | 28 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1996 | 299 | 0.010 |
Why?
|
Drug Storage | 1 | 1995 | 61 | 0.010 |
Why?
|
Ontario | 1 | 1995 | 112 | 0.010 |
Why?
|
Poisoning | 1 | 1996 | 113 | 0.010 |
Why?
|
Steroids | 1 | 1996 | 156 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 1999 | 2079 | 0.010 |
Why?
|
Proteinuria | 1 | 1994 | 98 | 0.010 |
Why?
|
Videotape Recording | 1 | 1994 | 36 | 0.010 |
Why?
|
Interview, Psychological | 1 | 1994 | 95 | 0.010 |
Why?
|
Cations | 1 | 1994 | 80 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1995 | 345 | 0.010 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 1973 | 18 | 0.010 |
Why?
|
Thiopental | 1 | 1993 | 2 | 0.010 |
Why?
|
Enflurane | 1 | 1993 | 2 | 0.010 |
Why?
|
Nitrous Oxide | 1 | 1993 | 12 | 0.010 |
Why?
|
Premedication | 1 | 1993 | 41 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 1994 | 310 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 1992 | 62 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1992 | 64 | 0.010 |
Why?
|
HIV Infections | 1 | 2007 | 2532 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1992 | 193 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 1992 | 102 | 0.010 |
Why?
|
Myocarditis | 1 | 1993 | 95 | 0.010 |
Why?
|
Asthma | 1 | 2005 | 2130 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 1995 | 1184 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1992 | 328 | 0.010 |
Why?
|
Diuretics | 1 | 1991 | 78 | 0.010 |
Why?
|
Eosinophilia | 1 | 1993 | 177 | 0.010 |
Why?
|
Sports Medicine | 1 | 1973 | 130 | 0.010 |
Why?
|
Infant, Low Birth Weight | 1 | 1992 | 130 | 0.010 |
Why?
|
Respiration | 1 | 1991 | 189 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 1992 | 440 | 0.010 |
Why?
|
Personality Tests | 1 | 1989 | 19 | 0.010 |
Why?
|
Hospitalization | 1 | 1998 | 1914 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1991 | 234 | 0.010 |
Why?
|
Triage | 1 | 1991 | 215 | 0.010 |
Why?
|
Color | 1 | 1989 | 82 | 0.010 |
Why?
|
Pulmonary Circulation | 1 | 1991 | 455 | 0.010 |
Why?
|
Aorta | 1 | 1991 | 368 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1994 | 1003 | 0.010 |
Why?
|
Peer Group | 1 | 1989 | 208 | 0.000 |
Why?
|
Osmolar Concentration | 1 | 1987 | 185 | 0.000 |
Why?
|
Cyanosis | 1 | 1987 | 18 | 0.000 |
Why?
|
Macrophages | 1 | 1994 | 1334 | 0.000 |
Why?
|
Posture | 1 | 1988 | 168 | 0.000 |
Why?
|
Signal Transduction | 1 | 1999 | 4902 | 0.000 |
Why?
|
Airway Obstruction | 1 | 1987 | 182 | 0.000 |
Why?
|
Pulmonary Artery | 1 | 1991 | 1097 | 0.000 |
Why?
|
Hemiplegia | 1 | 1982 | 19 | 0.000 |
Why?
|
Arterial Occlusive Diseases | 1 | 1982 | 81 | 0.000 |
Why?
|